Neogenomics Stock

Neogenomics FCF per Share

The Free Cash Flow per Share of Neogenomics (NEO) as of Sep 9, 2026 is -0.85 USD. In the previous year, Free Cash Flow per Share was -1.34 USD — a change of -37.01% (higher).

FCF per Share

-0.85USD

YoY

-37.01%

Last updated:

Free Cash Flow per Share of Neogenomics is 2026 -0.85 USD. Free Cash Flow per Share of Neogenomics was 2025 -1.34 USD. It decreases by -37.01% higher compared to the previous year.

The Neogenomics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
1.57 USD
Jan 1, 2019
0.15 USD
Jan 1, 2020
-1.21 USD
Jan 1, 2021
-3.69 USD
Jan 1, 2022
-3.88 USD
Jan 1, 2023
-1.22 USD
Jan 1, 2024
-1.34 USD
Jan 1, 2025
-0.85 USD
The Neogenomics FCF per Share history
YEARFCF per ShareYoY
-0.85USD-37.01%
-1.34USD+10.22%
-1.22USD-68.61%
-3.88USD+5.23%
-3.69USD+205.16%
-1.21USD-880.92%
0.15USD-90.15%
1.57USD+474.81%
0.27USD+54.07%
0.18USD-48.26%
0.34USD-24.15%
0.45USD
Access this data via the Eulerpool API

Neogenomics Stock analysis

What does Neogenomics do? Neogenomics Inc. is a leading company in the field of personalized medicine, based in Fort Myers, Florida. It offers integrated diagnostics and pharmaceutical services for oncology and gene therapy, with a focus on providing accurate diagnosis for cancer patients. Neogenomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogenomics stock

Free Cash Flow per Share of Neogenomics is -0.85 USD in 2026.

Free Cash Flow per Share of Neogenomics changed from -1.34 USD to -0.85 USD, representing a -37.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Neogenomics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Neogenomics

All Key Metrics — Neogenomics